Continuous renal replacement therapy after heart transplantation

Canadian Journal of Cardiology

Volumn 20, Issue 6, 2004, Pages 619-623

  Stevens, Louis Mathieu ^a   El Hamamsy, Ismaïl ^a   Leblanc, Martine ^b   Perrault, Louis P ^a   Pellerin, Michel ^a   Bouchard, Denis ^a   Carrier, Michel ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

Heart transplantation; Renal failure

Indexed keywords

BASILIXIMAB; CREATININE; CYCLOSPORIN A; DIPHENHYDRAMINE; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARACETAMOL; PREDNISONE; THYMOCYTE ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CANADA; CARDIOMYOPATHY; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG BLOOD LEVEL; FEMALE; HEART TRANSPLANTATION; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PROGNOSIS; RISK FACTOR; ACUTE KIDNEY FAILURE; HEMODIAFILTRATION; HEMOFILTRATION; LENGTH OF STAY; METABOLISM; MIDDLE AGED;

ADULT; CREATININE; FEMALE; HEART TRANSPLANTATION; HEMODIAFILTRATION; HEMOFILTRATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, ACUTE; LENGTH OF STAY; MALE; MIDDLE AGED;

EID: 2942736956     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bent P, Tan HK, Bellomo R, et al. Early and intensive continuous hemofiltration for severe renal failure after cardiac surgery. Ann Thorac Surg 2001;71:832-7.
2. Tsang GMK, Khan I, Dar M, Clayton D, Waller D, Patel RL. Hemofiltration in a cardiac intensive care unit: Time for a rational approach. ASAIO J 1996;42:M710-3.
3. Ostermann ME, Taube D, Morgan CJ, Evans TW. Acute renal failure following cardiopulmonary bypass: A changing picture. Intensive Care Med 2000;26:565-71.
4. Chertow GM, Lazarus JM, Christiansen CL, et al. Preoperative renal risk stratification. Circulation 1997;95:878-84.
5. Zanardo G, Michielon P, Paccagnella A, et al. Acute renal failure in the patient undergoing cardiac operation: Prevalence, mortality rate, and main factors. J Thorac Cardiovasc Surg 1994;107:1489-95.
6. Baudoin SV, Wiggins J, Keogh BF, Morgan CJ, Evans TW. Continuous veno-venous haemofiltration following cardiopulmonary bypass: Indications and outcome in 35 patients. Intensive Care Med 1993;19:290-3.
7. Greenberg A, Egel JW, Thompson ME, et al. Early and late forms of cyclosporine nephrotoxicity: Studies in cardiac transplant recipients. Am J Kidney Dis 1987;9:12-22.
8. Canver CC, Heisey DM, Nichols RD. Acute renal failure requiring hemodialysis immediately after heart transplantation portends a poor outcome. J Cardiovasc Surg 2000;41:203-6.
9. Ouseph R, Brier ME, Jacobs AA, Erbeck KM. Continuous venovenous hemofiltration and hemodialysis after orthotopic heart transplantation. Am J Kidney Dis 1998;32:290-4.
10. Macris MP, Ford EG, Van Buren CT, Frazier OH. Predictors of severe renal dysfunction after heart transplantation and intravenous cyclosporine therapy. J Heart Transplant 1989;8:444-9.
11. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
12. Brater CD. General principles of drug pharmacokinetics. In: Rose BD, Ed. UpToDate, 9.2 Edn. Wellesley: UpToDate; 2001.
13. Bellomo R, Ronco C. Continuous renal replacement therapy in the intensive care unit. Intensive Care Med 1999;25:781-9.
14. Kellum JA, Johnson JP, Kramer D, Palevsky P, Brady JJ, Pinsky MR. Diffusive vs convective therapy: Effects on mediators of inflammation in patients with severe systemic inflammatory response syndrome. Crit Care Med 1998;26:1995-2000.
15. Amyot SL, Leblanc M, Thibeault Y, Geadah D, Cardinal J. Myoglobin clearance and removal during continuous venovenous hemofiltration. Intensive Care Med 1999;25:1169-72.
16. Kellum JA, Angus DC, Johnson JP, et al. Continuous versus intermittent renal replacement therapy: A meta-analysis. Intensive Care Med 2002;28:29-37.
17. Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 2000;356:26-30.
18. Cantarovich M, Giannetti N, Cyr E, Chartier R, Cecere R. Improvement of acute renal dysfunction (ARD) in heart transplant (TX) patients (PTS) during calcineurin inhibitor (CNI) 'holiday' without rejection under anti-CD25 monoclonal antibody (MAB) coverage. J Heart Lung Transplant 2001;20:233.
19. Armitage JM, Kormos RL, Morita S, et al. Clinical trial of FK 506 immunosuppression in adult cardiac transplantation. Ann Thorac Surg 1992;54:205-11.
20. Reichart B, Meiser B, Viganò M, et al. European multicenter tacrolimus (FK506) heart pilot study: One-year results - European tacrolimus multicenter heart study group. J Heart Lung Transplant 1998;17:775-81.
21. Meiser BM, Überfuhr P, Fuchs A, et al. Single-center randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of acute myocardial rejection. J Heart Lung Transplant 1998;17:782-8.
22. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999;130:461-70.